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Evidence-based practice is seen as a cornerstone of modern medicine and 
healthcare more broadly.1 It describes a process where there is “explicit and 
judicious use of current best evidence in making decisions about the care of 
individual patients”.2 The whole of the dental team have a key part to play and the 
question we ask in this paper is when and how should we be accounting for the input 
of patients, the public, dental professionals, commissioners and policy-makers in the 
evidence generation process? We also make a plea to consider implementation 
during rather than after the evidence generation process. 
 
The process of generating evidence in the traditional model of evidence-based 
healthcare has been viewed to largely begin with randomised controlled clinical trials 
of clinical interventions, due to their ability to determine causality. Any observed 
effect is then pooled statistically across a number of similar trials, using a technique 
called meta-analysis (when possible) and the evidence then becomes synthesised to 
create evidence-based policies.3 This process of creating and distilling the available 
evidence forms the approach taken by groups such as Cochrane, York’s Centre for 
Review and Dissemination and the National Institute of Clinical Excellence. The 
systematic reviews produced sit at the pinnacle of the hierarchy of evidence (Figure 
1) to “provide accessible, credible information to support informed decision-making”.4  
 
Once the evidence has been produced, the next logical step is seen to be the 
translation of this evidence into routine practice. However, changing clinical 
behaviour is not straightforward. For example, a survey examining General Dental 
Practitioner’s (GDPs) behaviour before and after the publication of guidance on the 
use of fluoride varnish demonstrated no significant changes.5 Subsequent research 
found a number of barriers and facilitators to its use, which included: awareness of 
recommendations; professional identity; social influences and whether it was 
something the GDP wanted to do.6 Issues relating to the implementation of antibiotic 
prescribing guidance followed a similar pattern. The production of guidelines did not 
result in a direct change in GDP behaviour.7 Indeed, simply educating GDPs or 
incentivising clinical behaviour was found to be equally limiting.8 This highlights a key 
concern for funders of medical research. If research is not to be wasted, it must be 
designed appropriately and make an impact in real life. New studies should account 
for the lessons learnt from previous research, which in turn should be reported 
accurately.9,10 Modern trials undertaken in a dental context now conform to the 
design principles laid down by the Medical Research Council,11,12,13 but there remain 
challenges implementing the evidence generated. 
 
These problems have led to a rapid growth in “implementation science”, which is also 
known as “knowledge translation” or “knowledge mobilisation”. Many different 
definitions exist, but there is general agreement that it describes the “scientific study 
of methods to promote the uptake of research findings into routine healthcare in 
clinical, organisational or policy contexts”.14 Recognised implementation frameworks 
that are used in implementation science include Promoting Action on Research 
Implementation in Health Services (PARIHS) and Knowledge-To-Action (K2A).15,16 
PARIHS is a framework that maps out the elements that need attention before, 
during and after the process of implementation. It proposes that successful 
implementation is dependent on the complex interplay of the evidence to be 
implemented (how robust it is and how it fits with local experience), the local context 
in which implementation is to take place (the prevailing culture, leadership, and 
commitment to evaluation and learning) and the way in which the process is 
facilitated (how and by whom).17 The K2A framework describes a cycle of problem 
identification, local adaptation and assessment of barriers, implementation, 
monitoring and sustained use.6 Within the cycle, attention is paid to the knowledge 
creation process, developing knowledge synthesis and tools, and tailoring this to the 
local context (Figure 2), although common interpretations view the action cycle as 
the process of getting the evidence into practice, once it has been generated i.e. 
implementation is construed as a linear process after the evidence has already been 
generated. 
 
This form of thinking also pervades many interpretations of behaviour change 
theories, where the problem is commonly seen to lie again, at the interface between 
the end of the evidence production process and clinical practice. Behaviour change 
theories are then used to influence clinician’s behaviours to adopt this evidence, or 
understand why it is not being adopted. For example, Michie et al’s COM-B model is 
often over-simplified to explore a clinician’s Capability, Opportunity and Motivation to 
change.18,19Another theory used is the Normalization Process Theory (NPT). NPT 
identifies four determinants of embedding (i.e. normalizing) the evidence into clinical 
practice: coherence or sense making, cognitive participation or engagement, 
collective action and reflexive monitoring.20 Again, the emphasis is on “normalising” 
new evidence into practice, after the evidence has been generated.  
 
Despite the growing interest in frameworks to enhance the implementation process, 
the traditional approach of generating evidence and then implementing the evidence 
into practice is increasingly being seen as too simplistic. As argued by Raines et al., 
(2016) “the value of shifting from the traditionally used binary question of 
effectiveness, towards a more sophisticated exploration” is warranted, understanding 
the “characterisation of interventions and their contexts of implementation”.21 As 
highlighted later in the same report, knowledge translation is not a passive process. 
Many clinicians do not always engage with evidence-based practice and the 
effectiveness of interventions varies across different contexts.22,23,24,25 This problem 
leads to research waste, as evidence from funded studies does not translate into the 
desired change in clinical practice.26 As highlighted above, problems in 
implementation commonly occur because the interpretation of evidence is socially 
constructed i.e. interpreted differently across and within professions. In addition, it is 
often “weighed-up” alongside other clinical factors and experiential knowledge can be 
privileged.27,28,29 As a result, the production of evidence in its own right is not 
sufficient per se to facilitate translation.30  
 
A plea to consider implementation during the evidence generation process 
Over ten years ago Glasziou & Haynes described the stages that lead to change in 
clinical practice.31 They argued that the adoption of a new practice requires seven 
separate stages: 1. there has to be an awareness of the problem, 2. there needs to 
be an acceptance of the need to change current practice, 3. the intervention should 
be applicable to the right group, 4. it should be able to be delivered, 5. it is acted on 
by clinicians, 6. agreed to by patients and 7. adhered to by patients. This is 
represented diagrammatically in Figure 3. If we assume a 80% transitional probability 
at each stage, then the likelihood that the intervention will be adopted in clinical 
practice is only 21.0% (or a little over one in five). Although a number of assumptions 
are made in this model (e.g. that each stage follows another in a linear fashion), it 
highlights the impact of not taking context into account, and not involving different 
stakeholders at the very beginning of the evidence creation process.   
 
The central argument of this paper is that if evidence is to be successfully translated 
into clinical practice, far more attention needs to be paid to the context, mechanisms 
and conditions that lead to the generation of this evidence (particularly when the 
intervention is complex and involves human factors for success). This either ensures 
that the evidence created is more relevant to the patient and to the clinician, or it 
provides researchers and policy-makers with more of an understanding of why 
evidence is not being adopted. If more attention is paid to the context, the likelihood 
that the intervention will be adopted in clinical practice should in theory, improve. As 
highlighted by Moore et al. recently ”effect sizes do not provide policy makers with 
information on how an intervention might be replicated in their specific context, or 
whether trial outcomes will be reproduced”.32 Rather than waiting for the evidence to 
be produced and then engage implementation frameworks and behaviour change 
strategies to translate complex interventions into clinical practice, the emphasis 
should ideally move to using implementation frameworks to understand the context, 
mechanisms and conditions prior to, and as, the evidence is being generated.  
 
Equally, the co-production of interventions is being seen as increasingly important. 
Here, explicit attention is given to patients co-producing interventions with 
researchers and clinicians, particularly when the interventions are complex, for 
example, how services are designed.33,34 This approach, along with greater Patient 
and Public Involvement (PPI), potentially improves the transitional probabilities at 
each stage of Glasziou & Haynes model, by ensuring “buy-in” of patients and 
clinicians alike. Examples of co-production in healthcare include: (1) co-
commissioning of services; (2) co-design of services; (3) co-delivery of services and 
(4) co- assessment.35,36 In Scotland, a workshop involving over 600 patients (entitled 
“Moving on Together”) and 900 health professionals (entitled “Working in 
Partnership”) developed a educational tool for improving communication skills, 
strategies for articulating goals, collaborative problem solving and action planning 
and monitoring.37 Likewise, “ImproveCareNow” has resulted in the development of an 
electronic infrastructure to alter how patients, parents, clinicians and researchers 
engage the healthcare system.38 
 
Considering implementation during the evidence generation process also has a 
knock-on effect on how we potentially design trials, ensuring PPI and co-production 
is at the centre of feasibility studies and pre-, peri- and post trial processes. Here, the 
potential of using implementation frameworks more broadly before and during trial 
evidence generation, rather than after the evidence has been generated, is an 
emerging area of research that is currently being examined.39 
 
Implications for trial design when implementation is considered as a fore-
thought 
Patient and public involvement 
The active use of PPI in trials is increasing and is associated with higher recruitment 
rates in mental health studies.40,41,42 Reasons for better outcomes include the type of 
language used in patient facing information, insights into appropriate or least 
burdensome study designs and awareness of patient involvement improving the 
willingness to be involved.43 PPI should be carefully planned prior to research design, 
incorporating an iterative process where appropriate with clear guidance about 
roles.44 Despite this funding is limited in this area and standard operating procedures 
for PPI in Clinical Trial Units (CTUs) have been limited to post-funding activities.45 
Challenges ahead include developing an appropriate common language (to make 
trials understandable to patients),46 support at a CTU level to promote “pipeline to 
proposal” infrastructure,47 setting priorities, developing PPI within core outcome sets 
and understanding how to encourage co-design and co-production principles into trial 
design.48,49   
 
Feasibility and pilot studies 
We also argue that factors associated with implementation could be considered 
earlier at the feasibility stage. Feasibility studies are commonly conducted prior to 
definitive trials to test recruitment, retention and the acceptability and the fidelity of 
the intervention in the planned trial.50 For trials of complex interventions, an 
opportunity exists to explore how implementation frameworks could be used to 
inform the design of the definitive trial. This offers an opportunity to provide a 
theoretical underpinning to an exploration of “context”, thereby providing a better 
understanding of the pathway to impact along Glasziou & Haynes stages (2005). 
Methodological research looking at this and how feasibility studies inform definitive 
trials is being explored.34     
 
Process evaluations 
Although trials remain the best method for making causal inference and providing a 
reliable basis for decision-making, they often struggle to determine how or why a 
complex intervention (as opposed to an intervention that relies simply on pharaco-
dynamics) does or does not achieve outcomes. As a result, process evaluations are 
used alongside trials to help understand “the causal assumptions underpinning the 
intervention and use of evaluation to understand how interventions work in 
practice”.27 These are often run as parallel qualitative studies that explain 
“discrepancies between expected and observed outcomes, to understand how 
context influences outcomes, and to provide insights to aid further implementation”.51  
Process evaluation can usefully investigate how the intervention was delivered, 
providing decision-makers with information about how it might be replicated.  
 
Realist approaches to process evaluation are also increasingly being used. These 
have a particular focus on “what works, for whom, why and in what circumstances”.52 
Again, such an approach can help address many of the stages in Glasziou and 
Haynes’s model. Health service interventions commonly consist of a number of 
components that can act both independently and inter-dependently.53,54 They are 
also heavily influenced by the fidelity of the clinician, where learning effects can lead 
to non-linear processes.8,55,56 It is becoming increasingly recognised that irrespective 
of whether the intervention is complicated (detailed but predictable) or complex 
(detailed and unpredictable), an understanding of range of factors that influence the 
adoption of evidence is critical.32,57  
 
Implications of using implementation frameworks as part of trial design 
Intervention implementation (features and effectiveness) tend to be studied 
retrospectively (e.g. Damschroder & Lowery, 2013).58 However, in one example, 
Rycroft-Malone et al. (2013) conducted a prospective process evaluation of 
implementation processes that provided an explanation for the trial findings in a large 
implementation randomized controlled trials in acute care study focused on reducing 
peri-operative fasting times.59 Using theory-informed approaches or frameworks as 
part of trial design can help to understand the conditions or features which support 
intervention effectiveness, its implementation and ideally, how to achieve sustained 
practice change. 
 
As highlighted by Bain et al. (2016) research is increasingly emphasising the “many 
ways and levels at which context shapes service development”.60 Again, the use of 
implementation research is being seen as increasingly important to determine the 
barriers and enablers to translation and how patients experience the intervention, 
compared to how it was designed (Figure 4).61Although NPT and other frameworks 
have been used, many place too much emphasis on understanding change at an 
individual level rather than at a system level. 10,11,62,63,64,65 There is now an argument 
to move beyond this limited focus at a micro level to focus on system factors and 
broader processes at a meso and macro level, ensuring implementation science 
contributes to intervention development and pre, peri and post trial processes. As 
argued by Fitzpatrick & Raine (2016), we have “reached the point now where 
attention in terms of articulating, refining and developing principles can be given to a 
much wider array of methods“, over and above the classic approach of a definitive 
trial and systematic review.66 Table 1 suggests a range of methodologies to consider 
for future research. 
 
Conclusion 
The use of implementation as fore-thought has the potential to reduce the gap 
between the evidence generated and clinical practice, ensuring Glasziou and 
Haynes’s stages are given due consideration during (not after) evidence generation. 
It also has implications for policy-makers and in theory at least, could enable them to 







Table 1: Key issues to consider in the production of evidence 
Key questions Methods that apply to the question 
Is the area of research a key priority for patients, 
clinicians, policy-makers and commissioners?  
 
Is the right research question being asked?  
 
Are patients at the centre of the research process? 
Patient and Public Involvement 
Priority Setting Partnerships 
Prioritisation methods e.g. Discrete Choice 
Experiments  
Consensus methodologies e.g. Delphi 
Is the right intervention being tested? Patient and Public Involvement 
Co-creation and production e.g. Experience 
Based Co-Design 
Do researchers understand the context, within 
which the trial is situated? 
 
Do researchers understand the mechanisms and 
conditions that lead to the outcomes of the trial? 
 
Do researchers understand the interdependence of 
these factors and the fidelity of both clinicians and 
patients? 
Theoretically informed feasibility/pilot studies 
Theoretically driven process evaluation 
 
Do researchers understand the role of the observer 
and the observed within the trial? 
 
Do researchers understand how the magnitude and 
direction of the effect size in the trial is produced? 
Theoretically driven process evaluation 
 
How does the evidence generated from the trial get 
synthesised? 
Cochrane reviews 
Parallel realist syntheses  
How do these syntheses account for context? Realist syntheses and meta-ethnography 
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